Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni.
Pasquali
Frédérique
F
Lucchi
Alex
A
Manfreda
Gerardo
G
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002169:Campylobacter Infections / Q000382:microbiology; D016123:Campylobacter jejuni / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D002939:Ciprofloxacin / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D000077422:Enrofloxacin; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation / Q000187:drug effects*; D009268:Nalidixic Acid / Q000494:pharmacology*; D011200:Poultry
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D009268:Nalidixic Acid; D000077422:Enrofloxacin; D002939:Ciprofloxacin